By: Press Release | February 25, 2015
“We have long maintained that user fees paid by industry to FDA should not be treated under sequestration the same way as taxpayer dollars. The fees paid by medical technology companies under the 2012 Medical Device User Fee Agreement represent an agreement between industry, FDA and Congress. "
By: Press Release | February 23, 2015
“The conference will bring together senior executives, regulators, legal counsel, compliance professionals, international policymakers, distributor reps and industry observers to proactively share and discuss the major and emerging compliance trends and best practices,” White added
By: Statement | February 13, 2015
“AdvaMed commends the House for taking action to address certain expiring provisions of the tax code that are important to medical technology innovators.
March 10, 1:00 pm Eastern | Webinar
John Kelly (Bass, Berry & Sims) and Peter Leininger (FDA) will discuss key FDA enforcement tools and trends. During the hour-long webinar... more
March 12-13 | Topics to be covered include recent developments in government policy and diagnostics, molecular submissions, the OIR perspective, and the regulation of LDTs.more